PART I Item 1. B usiness Our Business Agenus is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious disease. Our primary business is immuno-oncology ("I-O"), where we are advancing antibody-based programs to activate innate and adaptive immunity, overcome tumor immune evasion and expand the population of patients who may benefit from immunotherapy. Our lead clinical program is botensilimab (BOT or AGEN1181), alone and in combinat...
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-16 | 2025-12-31 | 0001193125-26-108632 | EDGAR | 100K words |
| 2025-03-17 | 2024-12-31 | 0000950170-25-040289 | EDGAR | — |
| 2024-03-14 | 2023-12-31 | 0000950170-24-031620 | EDGAR | — |
| 2023-03-16 | 2022-12-31 | 0000950170-23-008517 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0001564590-22-007867 | EDGAR | — |
| 2021-03-16 | 2020-12-31 | 0001564590-21-013619 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0001564590-20-011221 | EDGAR | — |
| 2019-03-18 | 2018-12-31 | 0001564590-19-008311 | EDGAR | — |
| 2018-03-16 | 2017-12-31 | 0001564590-18-006093 | EDGAR | — |
| 2017-03-16 | 2016-12-31 | 0001564590-17-004618 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-07 | 2026-06-30 | 0001193125-26-340363 | EDGAR | — |
| 2025-11-10 | 2025-09-30 | 0001193125-25-274554 | EDGAR | 27K words |
| 2025-08-11 | 2025-06-30 | 0000950170-25-106633 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0000950170-25-069396 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0000950170-24-125608 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0000950170-24-093937 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0000950170-24-053951 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0000950170-23-062051 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0000950170-23-039768 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0000950170-23-019649 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0000950170-22-022915 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001564590-22-028592 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-11 | 0001193125-26-344783 | EDGAR | — |
| 2026-08-06 | 0001193125-26-336780 | EDGAR | — |
| 2026-07-13 | 0001193125-26-301414 | EDGAR | — |
| 2026-03-26 | 0001193125-26-125170 | EDGAR | 1K words |
| 2026-03-16 | 0001193125-26-107288 | EDGAR | — |
| 2026-01-16 | 0001193125-26-014678 | EDGAR | — |
| 2026-01-14 | 0001193125-26-012922 | EDGAR | — |
| 2026-01-08 | 0001193125-26-007706 | EDGAR | — |
| 2025-11-10 | 0001193125-25-273266 | EDGAR | — |
| 2025-10-09 | 0001193125-25-235819 | EDGAR | — |
265 total filings indexed. 233 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001098972 |
| Ticker | AGEN |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.agenusbio.com |
| Listed | 2000-02-04 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/AGEN (~200 tokens, structured JSON with cryptographic provenance)